STOCK TITAN

Alpha Teknova Financials

TKNO
Trailing 12 months to June 30, 2026
Revenue $43.7M +12.3% YoY
Net Income -$16.8M +22.0% YoY
EPS (Diluted) -$0.31 +24.4% YoY
Free Cash Flow -$7.4M +30.0% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Alpha Teknova (TKNO) reported $43.7M in revenue over the twelve months to Jun 30, 2026, up 12.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TKNO FY2025

Alpha Teknova’s recovery is driven by cost reduction and lower reinvestment, while losses and equity erosion remain embedded in operations.

Revenue returned to $40.5M in FY2025 while gross margin recovered to 33.2%, indicating improved cost absorption rather than merely more volume. Yet operating cash flow of -$8.6M and free cash flow of -$9.8M show that the accounting recovery still has not converted into cash generation.

Revenue in FY2025 nearly regained FY2022’s level, but gross margin remained below its earlier 42.2% structure, so the rebound does not represent fully restored unit economics. Lower selling, general and administrative spending helped narrow the operating margin loss to -41.9% from -69.3% in FY2024.

Shares outstanding almost doubled from 28.0M in FY2021 to 53.6M in FY2025, making dilution a more important balance-sheet change than debt buildup. Debt-to-equity remained modest at 0.2x, but total equity declined to $68.8M, showing that losses continued to reduce the capital base despite limited leverage.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 47 / 100
Financial Health Score 47/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Alpha Teknova's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
53
Dilution
37
R&D Intensity
20
Revenue Progress
55
Burn Trend
69
Balance Sheet
48
Altman Z-Score Safe
4.92

Alpha Teknova scores 4.92, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($382.3M) relative to total liabilities ($34.8M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

Alpha Teknova passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Alpha Teknova reported a net loss of $17.3M while operations used $8.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Alpha Teknova reported an operating loss of $17.0M against $710K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$40.5M
YoY+7.4%
5Y CAGR+5.3%

Alpha Teknova generated $40.5M in revenue in fiscal year 2025. This represents an increase of 7.4% from the prior year.

EBITDA
-$10.6M
YoY+45.7%

Alpha Teknova's EBITDA was -$10.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 45.7% from the prior year.

Net Income
-$17.3M
YoY+35.5%

Alpha Teknova reported -$17.3M in net income in fiscal year 2025. This represents an increase of 35.5% from the prior year.

EPS (Diluted)
-$0.32
YoY+43.9%

Alpha Teknova earned -$0.32 per diluted share (EPS) in fiscal year 2025. This represents an increase of 43.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$9.8M
YoY+27.5%

Alpha Teknova recorded an outflow of $9.8M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 27.5% from the prior year.

Cash & Debt
$5.9M
YoY+59.4%
5Y CAGR+12.3%

Alpha Teknova held $5.9M in cash against $13.1M in long-term debt as of fiscal year 2025.

Shares Outstanding
54M
YoY+0.3%

Alpha Teknova had 54M shares outstanding in fiscal year 2025. This represents an increase of 0.3% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
33.2%
YoY+14.0pp
5Y CAGR-23.6pp

Alpha Teknova's gross margin was 33.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 14.0 percentage points from the prior year.

Operating Margin
-41.9%
YoY+27.4pp
5Y CAGR-56.8pp

Alpha Teknova's operating margin was -41.9% in fiscal year 2025, reflecting core business profitability. This is up 27.4 percentage points from the prior year.

Net Margin
-42.6%
YoY+28.3pp
5Y CAGR-54.0pp

Alpha Teknova's net profit margin was -42.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 28.3 percentage points from the prior year.

Return on Equity
-25.1%
YoY+7.4pp
5Y CAGR-46.4pp

Alpha Teknova's ROE was -25.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 7.4 percentage points from the prior year.

Capital Allocation

R&D Spending
$2.2M
YoY-20.4%
5Y CAGR+7.8%

Alpha Teknova invested $2.2M in research and development in fiscal year 2025. This represents a decrease of 20.4% from the prior year.

Capital Expenditures
$1.1M
YoY+2.0%
5Y CAGR-26.8%

Alpha Teknova invested $1.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 2.0% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

TKNO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TKNO quarterly income statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue$12.2M+10.0%$11.1M+10.9%$10.0M-4.5%$10.5M+1.6%$10.3M+5.0%$9.8M+5.7%$9.3M-3.2%$9.6M
Cost of Revenue$7.3M+0.1%$7.3M+8.2%$6.7M-7.0%$7.2M+15.0%$6.3M-7.1%$6.8M-4.9%$7.1M-24.8%$9.5M
Gross Profit$4.9M+29.1%$3.8M+16.6%$3.2M+1.2%$3.2M-19.5%$4.0M+32.5%$3.0M+41.3%$2.1M+2264.4%$90K
R&D Expenses$554K-9.0%$609K+16.7%$522K-3.7%$542K-6.7%$581K+5.3%$552K-7.1%$594K-5.3%$627K
SG&A Expenses$4.8M-4.9%$5.1M-3.7%$5.3M+13.0%$4.6M-5.7%$4.9M-10.3%$5.5M+3.3%$5.3M+7.0%$5.0M
Operating Income-$2.9M+32.8%-$4.3M+6.7%-$4.6M-14.7%-$4.0M-18.6%-$3.4M+31.8%-$5.0M+11.8%-$5.6M+24.3%-$7.4M
Interest Expense-$252K-15.1%-$219K-3.8%-$211K-11.1%-$190K-15.2%-$165K-14.6%-$144K-11.6%-$129K+8.5%-$141K
Income Tax$30K-36.2%$47K+175.8%-$62K-178.5%$79K+315.8%$19K-13.6%$22K+157.9%-$38K-375.0%-$8K
Net Income-$3.2M+30.4%-$4.6M+4.3%-$4.8M-11.0%-$4.3M-20.1%-$3.6M+23.1%-$4.6M+18.8%-$5.7M+24.4%-$7.6M
EPS (Diluted)-$0.06+25.0%-$0.08+11.1%-$0.09-12.5%-$0.08-14.3%-$0.07+22.2%-$0.09+10.0%-$0.10+33.3%-$0.15

TKNO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TKNO quarterly balance sheet
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Total Assets$95.9M-2.8%$98.7M-4.8%$103.6M-3.8%$107.6M-2.6%$110.5M-3.1%$114.0M-4.0%$118.8M-4.3%$124.1M
Current Assets$30.8M-2.7%$31.7M-8.2%$34.5M-5.6%$36.6M-3.9%$38.1M-4.2%$39.7M-7.1%$42.8M-6.9%$45.9M
Cash & Equivalents$6.0M+39.4%$4.3M-27.2%$5.9M+84.5%$3.2M-2.2%$3.3M-3.0%$3.4M-8.9%$3.7M-39.7%$6.1M
Inventory$6.9M+0.5%$6.9M-2.6%$7.1M+2.0%$6.9M-9.1%$7.6M+15.8%$6.6M-3.4%$6.8M-11.4%$7.7M
Accounts Receivable$5.4M-4.7%$5.7M+22.8%$4.6M-10.1%$5.1M-0.1%$5.1M-8.5%$5.6M+30.2%$4.3M-6.4%$4.6M
Total Liabilities$33.3M-1.3%$33.7M-3.1%$34.8M-0.5%$35.0M+1.6%$34.4M-2.7%$35.4M-2.7%$36.4M-1.2%$36.8M
Current Liabilities$6.9M-0.3%$6.9M-8.5%$7.5M+8.7%$6.9M+7.1%$6.5M-8.0%$7.0M-37.2%$11.2M+15.4%$9.7M
Long-Term Debt$13.2M+0.4%$13.2M+0.4%$13.1M+0.4%$13.1M+0.3%$13.0M+0.3%$13.0M+37.6%$9.4M-13.0%$10.9M
Total Equity$62.6M-3.6%$64.9M-5.6%$68.8M-5.3%$72.7M-4.5%$76.1M-3.2%$78.6M-4.6%$82.4M-5.6%$87.3M
Retained Earnings-$143.5M-2.3%-$140.3M-3.4%-$135.8M-3.6%-$131.0M-3.4%-$126.7M-2.9%-$123.2M-3.9%-$118.5M-5.1%-$112.8M

Not reported in any period shown, so not listed: Goodwill.

TKNO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TKNO quarterly cash flow statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Cash Flow-$471K+86.0%-$3.4M-627.1%-$462K+76.7%-$2.0M+5.8%-$2.1M+48.8%-$4.1M-338.4%-$936K+54.5%-$2.1M
Capital Expenditures$125K-43.4%$221K-36.5%$348K-10.1%$387K+87.0%$207K+0.5%$206K-63.7%$567K+71.3%$331K
Free Cash Flow-$596K+83.4%-$3.6M-342.0%-$810K+65.8%-$2.4M-2.6%-$2.3M+46.4%-$4.3M-186.7%-$1.5M+37.1%-$2.4M
Investing Cash Flow$1.9M+5.6%$1.8M-42.6%$3.2M+95.5%$1.6M-19.1%$2.0M-47.0%$3.8M+370.4%-$1.4M+94.5%-$25.8M
Financing Cash Flow$224K+354.5%-$88K-137.8%-$37K-113.8%$268K+1057.1%-$28K+46.2%-$52K+40.2%-$87K-100.6%$15.4M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

TKNO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

TKNO quarterly financial ratios
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Gross Margin40.1%+5.9pp34.2%+1.7pp32.5%+1.8pp30.7%-8.1pp38.7%+8.0pp30.7%+7.7pp23.0%+22.0pp0.9%
Operating Margin-23.7%+15.1pp-38.8%+7.4pp-46.2%-7.7pp-38.4%-5.5pp-32.9%+17.8pp-50.7%+10.1pp-60.7%+16.9pp-77.6%
Net Margin-26.0%+15.1pp-41.1%+6.5pp-47.7%-6.7pp-41.0%-6.3pp-34.7%+12.7pp-47.4%+14.3pp-61.7%+17.3pp-79.0%
Return on Equity-5.1%+2.0pp-7.0%-0.1pp-6.9%-1.0pp-5.9%-1.2pp-4.7%+1.2pp-5.9%+1.0pp-6.9%+1.7pp-8.7%
Return on Assets-3.3%+1.3pp-4.6%0.0pp-4.6%-0.6pp-4.0%-0.8pp-3.2%+0.8pp-4.1%+0.8pp-4.8%+1.3pp-6.1%
Current Ratio4.49-0.1x4.590.0x4.58-0.7x5.27-0.6x5.87+0.2x5.64+1.8x3.82-0.9x4.73
Debt-to-Equity0.210.0x0.200.0x0.190.0x0.180.0x0.170.0x0.17+0.1x0.110.0x0.12
FCF Margin-4.9%+27.4pp-32.3%-24.2pp-8.1%+14.5pp-22.6%-0.2pp-22.4%+21.6pp-44.0%-27.8pp-16.2%+8.7pp-25.0%

Similar Companies

Frequently Asked Questions

What is Alpha Teknova's annual revenue?

Alpha Teknova (TKNO) reported $40.5M in total revenue for fiscal year 2025. This represents a 7.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Alpha Teknova's revenue growing?

Alpha Teknova (TKNO) revenue grew by 7.4% year-over-year, from $37.7M to $40.5M in fiscal year 2025.

Is Alpha Teknova profitable?

No, Alpha Teknova (TKNO) reported a net income of -$17.3M in fiscal year 2025, with a net profit margin of -42.6%.

Alpha Teknova (TKNO) reported diluted earnings per share of -$0.32 for fiscal year 2025. This represents a 43.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Alpha Teknova (TKNO) had EBITDA of -$10.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Alpha Teknova (TKNO) had $5.9M in cash and equivalents against $13.1M in long-term debt.

Alpha Teknova (TKNO) had a gross margin of 33.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Alpha Teknova (TKNO) had an operating margin of -41.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Alpha Teknova (TKNO) had a net profit margin of -42.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Alpha Teknova (TKNO) has a return on equity of -25.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Alpha Teknova (TKNO) recorded an outflow of $9.8M in free cash flow during fiscal year 2025. This represents a 27.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Alpha Teknova (TKNO) recorded an outflow of $8.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Alpha Teknova (TKNO) had $103.6M in total assets as of fiscal year 2025, including both current and long-term assets.

Alpha Teknova (TKNO) invested $1.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Alpha Teknova (TKNO) invested $2.2M in research and development during fiscal year 2025.

Alpha Teknova (TKNO) had 54M shares outstanding as of fiscal year 2025.

Alpha Teknova (TKNO) had a current ratio of 4.58 as of fiscal year 2025, which is generally considered healthy.

Alpha Teknova (TKNO) had a debt-to-equity ratio of 0.19 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Alpha Teknova (TKNO) had a return on assets of -16.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, Alpha Teknova (TKNO) held $21.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $8.6M over that year. Dividing the one by the other, the reported balance equals about 30 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Alpha Teknova (TKNO) has an Altman Z-Score of 4.92, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Alpha Teknova (TKNO) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Alpha Teknova (TKNO) reported a net loss of $17.3M while operations used $8.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Alpha Teknova (TKNO) reported an operating loss of $17.0M against $710K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Alpha Teknova (TKNO) scores 47 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top